(PRESS RELEASE) STOCKHOLM, 9-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its EQT Future fund, the firm’s new impact-driven longer-hold investment strategy, is co-investing in the SHL Medical, a world-leading provider of drug delivery solutions. … Read the full press release →
Posted in Business, Germany, Healthcare, Investment, Management, News, Pharma & Biotech, Sweden, Switzerland
Tagged Andreas Aschenbrenner, ATHOS, autoinjectors, biologic drugs, biosimilar derivatives, Biotech, drug delivery solutions, EQT, EQT Future, Healthcare, life sciences, medical autoinjectors, patient autonomy, Pharmaceutical, Rikke Kjær Nielsen, Roger Samuelsson, SHL Medical, Ulrich Faessler, Wolfgang Essler